• Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Bulgaria Croatia Czechia Estonia Germany +8

  • Study of Ramucirumab and Erlotinib for Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effects of Alpha-1-Proteinase Inhibitor for Patients with Pulmonary Emphysema Due to Alpha-1 Antitrypsin Deficiency

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Finland France Poland Sweden

  • Study on Talazoparib for Maintenance Treatment in Patients with Advanced Malignant Pleural or Peritoneal Mesothelioma After Initial Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Safety and Effectiveness of Olaparib, Ceralasertib, and AZD1775 for Patients with Metastatic Triple Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland Portugal Spain

  • Study of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Denmark France Germany Hungary +4

  • Study of Belantamab Mafodotin for Patients with Relapsed or Refractory AL Amyloidosis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy The Netherlands

  • Study on the Safety and Effectiveness of Azetukalner for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain

  • Study on the Effectiveness of Relatlimab, Ipilimumab, and Nivolumab in Patients with High-Risk Clear Cell Renal Cell Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

powered by